Wednesday, April 10, 2024 | 3:30 PM
Gillian Gittens
Director, e-Clinical Strategy and Solutions
Avani Amin
Associate Director, Client Solutions
Gillian Gittens, Director of eClinical Strategy and Solutions and Avani Amin, Associate Director of Client Solutions, discuss various aspects of TMF oversight. They emphasize the importance of starting TMF oversight from the beginning of a study and how it’s an essential part of the wider trial oversight requirement. The discussion covers key areas of TMF oversight including quality, completeness, and timeliness. They highlight the significance of using the metrics and data generated by TMF systems and how to effectively analyze and use these reports to drive decision-making and compliance.